Condition: Cardiac Failure · Graft Rejection · Sponsor: Inova Health Care Services
This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulation.
This description comes directly from the study's public registry record.
Palak Shah, MD · (703) 776-8000 · palak.shah@inova.org
Stephanie Wolak, MPH · 571-472-8558 · stephanie.wolak@inova.org
Always discuss trial participation with your own doctor first.
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Columbia University | New York, New York, United States | Recruiting |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | Recruiting |
| Vanderbilt University | Nashville, Tennessee, United States | Recruiting |
| Texas Children's Hospital | Houston, Texas, United States | Recruiting |
| Inova Health System | Falls Church, Virginia, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06532890